Becton Dickinson and Co's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 3 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 211.53.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of Becton Dickinson and Co is 8.98, ranking 21 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 5.89B, representing a year-over-year increase of 8.35%, while its net profit experienced a year-over-year increase of 23.25%.
Key Metrics
The current valuation score of Becton Dickinson and Co is 7.31, ranking 96 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 36.00, which is 62.64% below the recent high of 58.55 and 15.32% above the recent low of 30.49.
The current earnings forecast score of Becton Dickinson and Co is 7.00, ranking 146 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 201.92, with a high of 265.34 and a low of 183.00.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of Becton Dickinson and Co is 8.94, ranking 21 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 216.86 and the support level at 199.41, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of Becton Dickinson and Co is 10.00, ranking 1 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 98.17%, representing a quarter-over-quarter decrease of 0.83%. The largest institutional shareholder is The Vanguard, holding a total of 36.52M shares, representing 12.82% of shares outstanding, with 31.82% increase in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Becton Dickinson and Co is 9.33, ranking 11 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.26. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Becton Dickinson and Co’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.
